Webinar Part 1: Leveraging AI within eBV to speed access to therapy

By Myra Reinhardt; Shanna Barnes |

Explore the best combination of tech + human expertise

What approach to electronic benefit verification (eBV) is the right solution for now and into the future? eBV technology has changed. While logic-based approaches still have their place, AI has opened up a path to improved access for patients and added benefits for all stakeholders. For manufacturers, working with a patient service provider that blends compassionate human expertise with technology-based resources offers the best chance of optimizing speed to therapy in the increasingly complex and collaborative pharma ecosystem.

Hear from Lash Group’s Myra Reinhardt, VP, Product Innovation and Analytics, and Shanna Barnes, VP, New Business Development, as they share their extensive knowledge of access solutions and patient support.

In Part 1 of this two-part series, you’ll:

  • Gain information on the technology and approach that help accelerates speed to therapy
  • Identify drivers that impact eBV effectiveness 

*Q&A is not included in the on demand recording.


About the Authors

Myra Reinhardt

Vice President, Product Innovation & Analytics
Lash Group
As the Vice President of Product Innovation and Analytics, Myra Reinhardt brings expertise in strategic planning, product development and deploying large-scale technology solutions. Focused on product and analytics, she is responsible for the delivery and implementation of solutions that support the growth of the Lash Group business.
View Bio

Shanna Barnes

Vice President, Business Development
Lash Group
Shanna Barnes, Vice President, Business Development, brings expertise in building long-term client relationships and delivering results. She works closely with manufacturers to help build all-encompassing service solutions that meet the needs of patients and providers. 
View Bio